Dear Partners and Friends,
As the COVID-19 pandemic progresses and data accumulated to date, more and more attention is being paid to cellular immunity to SARS-CoV-2. As with many other viral diseases, it plays an essential role in dealing with the infection.
Some studies show that over time, there is a decrease in specific antibodies that are formed in the body after illness or vaccination, while T-cell immunity is a more reliable long-term indicator of previous encounter with the virus and built immunity. The combined assessment of humoral and cellular immunity gives a more complete picture of the immune status of SARS-CoV-2.
One of the main methods for assessing cellular immunity is the measurement of T-lymphocyte levels of interferon gamma after stimulation with virus antigens.
RIDACOM is pleased to present to your attention WANTAI SARS-CoV-2 IGRA test:
- The first CE-IVD certified SARS-CoV-2 test for quantitative measurement of interferon gamma levels by the ELISA method
- It is used to assess cellular immunity after infection or vaccination
- Supports the diagnosis of SARS-CoV-2 infection
More information can be found at: https://ridacom.com/en/products/view/7553
You can get acquainted with our full portfolio of high-quality diagnostic solutions for SARS-CoV-2 by the ELISA method at: https://ridacom.com/en/product-list/724/ELISA-Kits
Do not hesitate to contact us with additional questions!